Invention Grant
- Patent Title: Compound having HSP90 inhibitory activity or pharmaceutically acceptable salt thereof, and medical use thereof
-
Application No.: US16073342Application Date: 2017-01-31
-
Publication No.: US10464907B2Publication Date: 2019-11-05
- Inventor: Young Ho Seo
- Applicant: INDUSTRY ACADEMIC COOPERATION FOUNDATION KEIMYUNG UNIVERSITY
- Applicant Address: KR Daegu
- Assignee: INDUSTRY ACADEMIC COOPERATION FOUNDATION KEIMYUNG UNIVERSITY
- Current Assignee: INDUSTRY ACADEMIC COOPERATION FOUNDATION KEIMYUNG UNIVERSITY
- Current Assignee Address: KR Daegu
- Agency: Revolution IP, PLLC
- Priority: KR10-2016-0011622 20160129; KR10-2016-0011626 20160129
- International Application: PCT/KR2017/001034 WO 20170131
- International Announcement: WO2017/131500 WO 20170803
- Main IPC: C07D241/04
- IPC: C07D241/04 ; A23L33/10 ; A61P25/28 ; A61P31/12 ; A61P25/16 ; A61P35/00 ; C07C235/60 ; C07C237/42

Abstract:
The present invention relates to a novel compound having HSP90 inhibitory activity or a pharmaceutically acceptable salt thereof, and a medicinal use thereof, and composition comprising a dihydroxyphenyl compound or a benzamide compound, which is a novel compound having the HSP90 inhibitory activity of the present invention can effectively inhibit HSP90, and thus can be usefully used as a pharmaceutical composition for preventing or treating HSP90-mediated diseases or a health functional food for preventing or improving HSP90-mediated diseases, which selected from the group consisting of cancer diseases, degenerative neurological diseases and viral infections.
Public/Granted literature
Information query